Early storage lesions in apheresis platelets are induced by the activation of the integrin αIIbβ3 and focal adhesion signaling pathways

Journal of Proteomics

Volumn 76, Issue , 2012, Pages 297-315

  Thiele, Thomas ^a   Iuga, Cristina ^a,b   Janetzky, Susann ^a   Schwertz, Hansjorg ^c   Gesell Salazar, Manuela ^a   Fürll, Birgit ^a   Völker, Uwe ^a   Greinacher, Andreas ^a   Steil, Leif ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Apheresis; Integrin IIb 3; Platelet additive solution; Platelet storage lesion

Indexed keywords

ACTIN; ADENOSINE DIPHOSPHATE; ALBUMIN; ALPHA ACTININ 1; BETA TUBULIN; CLUSTERIN; COLLAGEN; FIBRINOGEN; FILAMIN A; INTEGRIN ALPHA2B BETA3; KHELLIN; MESSENGER RNA; MYOSIN; PADGEM PROTEIN; PLECKSTRIN; PREALBUMIN; TALIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; VINCULIN; ZYXIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; ELECTROSPRAY MASS SPECTROMETRY; FOCAL ADHESION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD PROTEINS; FOCAL ADHESIONS; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELETPHERESIS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84869875526     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.04.057     Document Type: Article

References (50)

1. Klinger M.H. The storage lesion of platelets: ultrastructural and functional aspects. Ann Hematol 1996, 73:103-112.
2. Ringwald J., Zimmermann R., Eckstein R. The new generation of platelet additive solution for storage at 22 degrees C: development and current experience. Transfus Med Rev 2006, 20:158-164.
3. Klein H.G. Pathogen inactivation technology: cleansing the blood supply. J Intern Med 2005, 257:224-237.
4. Vassallo R.R., Adamson J.W., Gottschall J.L., Snyder E.L., Lee W., Houghton J., et al. In vitro and in vivo evaluation of apheresis platelets stored for 5days in 65% platelet additive solution/35% plasma. Transfusion 2010, 50:2376-2385.
5. Zhang J.G., Carter C.J., Culibrk B., Devine D.V., Levin E., Scammell K., et al. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion 2008, 48:847-856.
6. Schwertz H., Tolley N.D., Foulks J.M., Denis M.M., Risenmay B.W., Buerke M., et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 2006, 203:2433-2440.
7. Weyrich A.S., Schwertz H., Kraiss L.W., Zimmerman G.A. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost 2009, 7:241-246.
8. Schubert P., Devine D.V. De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang 2010, 99:112-122.
9. Schwertz H., Koster S., Kahr W.H., Michetti N., Kraemer B.F., Weitz D.A., et al. Anucleate platelets generate progeny. Blood 2010, 115:3801-3809.
10. Thiele T., Steil L., Gebhard S., Scharf C., Hammer E., Brigulla M., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007, 47:1221-1233.
11. Thon J.N., Schubert P., Duguay M., Serrano K., Lin S., Kast J., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008, 48:425-435.
12. Glenister K.M., Payne K.A., Sparrow R.L. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. Transfusion 2008, 48:99-107.
13. Mohr H., Steil L., Gravemann U., Thiele T., Hammer E., Greinacher A., et al. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009, 49:2612-2624.
14. Thiele T., Steil L., Volker U., Greinacher A. Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine. BioDrugs 2007, 21:179-193.
15. Moog R., Zeiler T., Heuft H.G., Stephan B., Fischer E.G., Kretschmer V., et al. Collection of WBC-reduced single-donor PLT concentrates with a new blood cell separator: results of a multicenter study. Transfusion 2003, 43:1107-1114.
16. Holme S., Moroff G., Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998, 38:31-40.
17. Vetlesen A., Mirlashari M.R., Ezligini F., Kjeldsen-Kragh J. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007, 47:126-132.
18. Steil L., Thiele T., Hammer E., Bux J., Kalus M., Volker U., et al. Proteomic characterization of freeze-dried human plasma: providing treatment of bleeding disorders without the need for a cold chain. Transfusion 2008, 48:2356-2363.
19. Licht C., Pluthero F.G., Li L., Christensen H., Habbig S., Hoppe B., et al. Platelet-associated complement factor H in healthy persons and patients with atypical HUS. Blood 2009, 114:4538-4545.
20. Rowley J.W., Oler A.J., Tolley N.D., Hunter B.N., Low E.N., Nix D.A., et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011, 118:e101-e111.
21. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25.
22. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
23. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
24. Wee J.L., Jackson D.E. The Ig-ITIM superfamily member PECAM-1 regulates the "outside-in" signaling properties of integrin alpha(IIb)beta3 in platelets. Blood 2005, 106:3816-3823.
25. Li Y., Reznichenko M., Tribe R.M., Hess P.E., Taggart M., Kim H., et al. Stretch activates human myometrium via ERK, caldesmon and focal adhesion signaling. PLoS One 2009, 4:e7489.
26. Havasi A., Wang Z., Gall J.M., Spaderna M., Suri V., Canlas E., et al. Hsp27 inhibits sublethal, Src-mediated renal epithelial cell injury. Am J Physiol Renal Physiol 2009, 297:F760-F768.
27. Bauer K., Kratzer M., Otte M., de Quintana K.L., Hagmann J., Arnold G.J., et al. Human CLP36, a PDZ-domain and LIM-domain protein, binds to alpha-actinin-1 and associates with actin filaments and stress fibers in activated platelets and endothelial cells. Blood 2000, 96:4236-4245.
28. Feng S., Lu X., Resendiz J.C., Kroll M.H. Pathological shear stress directly regulates platelet alphaIIbbeta3 signaling. Am J Physiol Cell Physiol 2006, 291:C1346-C1354.
29. Jurk K., Schulz A.S., Kehrel B.E., Rapple D., Schulze H., Mobest D., et al. Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3. Thromb Haemost 2010, 103:1053-1064.
30. Gong H., Shen B., Flevaris P., Chow C., Lam S.C., Voyno-Yasenetskaya T.A., et al. G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin "outside-in" signaling. Science 2010, 327:340-343.
31. Kanchanawong P., Shtengel G., Pasapera A.M., Ramko E.B., Davidson M.W., Hess H.F., et al. Nanoscale architecture of integrin-based cell adhesions. Nature 2010, 468:580-584.
32. Schubert P., Devine D.V. Towards targeting platelet storage lesion-related signaling pathways. Blood Transfus 2010, 8(Suppl. 3):s69-s72.
33. Thiele T., Steil L., Volker U., Greinacher A. Transfusion medicine and proteomics. Alliance or coexistence?. Blood Transfus 2010, 8(Suppl. 3):s16-s25.
34. Liumbruno G.M. Proteomics: applications in transfusion medicine. Blood Transfus 2008, 6:70-85.
35. Liumbruno G.M., Aubuchon J.P. Old blood, new blood or better stored blood?. Blood Transfus 2010, 8:217-219.
36. Panzer S., Jilma P. Methods for testing platelet function for transfusion medicine. Vox Sang 2011, 101:1-9.
37. Michelson A.D., Furman M.I. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol 1999, 6:342-348.
38. Diedrich B., Sandgren P., Jansson B., Gulliksson H., Svensson L., Shanwell A. In vitro and in vivo effects of potassium and magnesium on storage up to 7days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008, 94:96-102.
39. Schubert P., Thon J.N., Walsh G.M., Chen C.H., Moore E.D., Devine D.V., et al. A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration. Transfusion 2009, 49:1944-1955.
40. Schubert P., Devine D.V. Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality. J Proteomics 2010, 73:436-444.
41. Moser M., Legate K.R., Zent R., Fassler R. The tail of integrins, talin, and kindlins. Science 2009, 324:895-899.
42. Ye F., Kim C., Ginsberg M.H. Reconstruction of integrin activation. Blood 2012, 119:26-33.
43. Sun L., Mao G., Rao A.K. Association of CBFA2 mutation with decreased platelet PKC-theta and impaired receptor-mediated activation of GPIIb-IIIa and pleckstrin phosphorylation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation. Blood 2004, 103:948-954.
44. Baig A., Bao X., Wolf M., Haslam R.J. The platelet protein kinase C substrate pleckstrin binds directly to SDPR protein. Platelets 2009, 20:446-457.
45. Lian L., Wang Y., Flick M., Choi J., Scott E.W., Degen J., et al. Loss of pleckstrin defines a novel pathway for PKC-mediated exocytosis. Blood 2009, 113:3577-3584.
46. Baig A., Bao X., Haslam R.J. Proteomic identification of pleckstrin-associated proteins in platelets: possible interactions with actin. Proteomics 2009, 9:4254-4258.
47. Naik M.U., Stalker T.J., Brass L.F., Naik U.P. JAM-A protects from thrombosis by suppressing integrin alphaIIbbeta3-dependent outside-in signaling in platelets. Blood 2012 Apr 5, 119(14):3352-3360.
48. Schoenwaelder S.M., Yuan Y., Cooray P., Salem H.H., Jackson S.P. Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. J Biol Chem 1997, 272:1694-1702.
49. Yan B., Calderwood D.A., Yaspan B., Ginsberg M.H. Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. J Biol Chem 2001, 276:28164-28170.
50. Thon J.N., Devine D.V. Translation of glycoprotein IIIa in stored blood platelets. Transfusion 2007, 47:2260-2270.